InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: SAMNOTSAMUEL post# 29726

Wednesday, 01/10/2018 11:25:47 AM

Wednesday, January 10, 2018 11:25:47 AM

Post# of 50157
Sam,

My reaction exactly when I first read the article. Good news that they are confident that expanding the parameters to more lesions will not negatively impact the phase 3 trial, but on the other hand, if enrollment was on a good pace for completion, there was not a need for the expansion.

So this PR and development might not be the price catalyst people will want it to be.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News